TP-1454

N/A

Report date: 2025/05/20 16:56:14
NME

Base Information

Drug NameTP-1454
Drug Alias NameTP-1454
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate kinase isozymes M1/M2 activators
TargetsPyruvate kinase isozymes M1/M2
Therapy Area/IndicationsSolid tumoursAnus Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTolero Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Pharma America Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursAnus Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A